SCHEMBL2573085

SCHEMBL2573085

CCN(CC)c1ccc(-c2csc(N)n2)cc1F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.57
ALDH1A1 P00352 9/20 0.57
NPC1 O15118 7/20 0.57
SMN1; SMN2 Q16637 7/20 0.57
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
MPL P40238 1/20 0.51
ALOX5 P09917 1/20 0.50
MAPT P10636 8/20 0.49
KDM4E B2RXH2 3/20 0.49
ALOX5AP P20292 1/20 0.47
FEN1 P39748 1/20 0.47
NFKB1 P19838 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
AR P10275 1/20 0.47
GFER P55789 1/20 0.47
LTA4H P09960 5/20 0.43
HPGD P15428 2/20 0.43
TP53 P04637 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626497 0.86 ALDH1A1 (0.49) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL19625367 0.83 CYP3A4 (0.40) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL126685 0.77 MPL (0.69) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL172198 0.76 LTA4H (0.54) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL1689576 0.76 RAB9A (0.66) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL17626112 0.76 CYP3A4 (0.43) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL29085894 0.76 RAB9A (0.65) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
Bromide SCHEMBL6832827 0.75 RAB9A (0.56) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL25242184 0.73 RAB9A (0.61) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL2762257 0.73 MPL (0.63) RAB9AALDH1A1NPC1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132017-A1 PYRIDO[3,4-D]PYRIMIDINYL ACETAMIDE DERIVATIVES AS TRPA1 MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed